To meet the moving target of best practice, production facilities regularly need updating or redesigning. MD Eric Schmidhäuser, explains how CMO Catalent reconfigured its Schorndorf site in Germany while maintaining customer orders and expectations.
Opened in 1996, Catalent’s 221,000ft2 Schorndorf site comprises two facilities for the manufacture and packaging of controlled release and oral dose forms, and for clinical trial supply services. The controlled release manufacturing facility had grown organically over a decade of operations to meet changing regulatory, customer and market demands. While significant efforts had been made to keep the facility, equipment, materials and workflow logical, the continued advance of manufacturing and regulatory best practice eventually necessitated a significant re-assessment of the site layout and operations.
Following lengthy evaluations, the management team decided that a fundamental redesign and improvement in the facility’s layout was required. Due to increased customer demand, Catalent wanted to transform Schorndorf into a European base for the development and supply of complex oral solids.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cleanroom Technology.
Subscribe now Already a subscriber? Sign in here.